And I Just Can’t Hide It


RTÉ website this morning

This morning.

Via RTÉ:

Speaking on RTÉ’s Morning Ireland, Waterford pharmacist Daragh Connolly said it was a “very exciting day” for pharmacists who were “delighted” to be at the heart of fighting Covid-19.

He said his own pharmacy had to close off its registration list for the 18 to 34 cohort as over 150 people had already registered….

How exciting?

Pharmacists get €35 per dose plus €10 for each patient entered into the ‘system’.

Not all heroes wear capes.

Pharmacies ‘excited’ as 18-34 cohort vaccinations under way (RTÉ)

Sponsored Link

26 thoughts on “And I Just Can’t Hide It

  1. Micko

    “ over 150 people had already registered”

    150? Is that all? The way the pharmacies are going on about them being inundated with calls, I thought there’d be WAY more. Thousands for each pharmacy.

    Probably just all young waiters and waitresses who want to keep their jobs serving boomers their dinner. ;p

      1. Micko

        I know.

        Small numbers. Thought it would be been thousands at each pharmacy the way they’re going on being inundated with calls.

        As I said above. “Thousands for each pharmacy”

        150 is a joke

          1. Cian

            AFAIK there is always a 15-minute wait after any jab; Pharmacies have been distributing the flu jab for years so would be able to cope with that.

        1. george

          Micko you could read the article before you post.

          There are 200,000 doses expected to be available so with 750 pharmacies that would be an average of 233 per pharmacy. There are not enough doses for each pharmacy to do 1000s in a month and of course they have to do their normal work at the same time.

          The article states that the pharmacy in question has stopped taking names at 150 because they cannot be sure of exact amount of doses they will get. It doesn’t say 150 is the maximum number of doses they can or will administer.

  2. Slave to the Rhythm

    delighted for them
    the pharmacy industry
    they have had such a tough time of it during COVID

  3. Chimpy

    I cant understand the curmudgeonly posts about covid. What is the story? I get it we’re all a bit browned off with this pandemic but we’re making steady progress here. Why not just applaud it and move on. It is a positive not a negative.

    1. Micko

      Encouraging and allowing healthy young adults to get a vaccine who’s long term side effects are unknown is a bad idea.

        1. Micko


          How about, vaccinate the vulnerable and defer the vaccination of anyone young and healthy – especially if they want to have kids.

          Defer for at least for a couple of years.

          Once we know the (potential) long term effects of these brand new medicines, only then should we give it to the next generation.

          It’s too quick. We’ve no idea what could happen and what could be passed to future generations.

          1. Jeffrey

            Because we have an idea what Covid and Long Covid will do to the future generations? You absolute dose. The vaccine has been already given by millions doses, it is our way out of this mess.

      1. Cian

        Encouraging and allowing healthy young adults to get a “natural immunity” by being exposed to a new virus who’s long term side effects are unknown is also a bad idea.

        The question is: are the known and unknown side effects of the vaccine(s) better or worse than the known and unknown side effects of catching Covid. With different answers for the different vaccines, and the different age groups (and possibly the different variants).

        1. Micko

          “ exposed to a new virus who’s long term side effects are unknown”

          Have you seen any peer reviewed studies on long covid?

          1. Cian


            Conclusions and future directions

            The multi-organ sequelae of COVID-19 beyond the acute phase of infection are increasingly being appreciated as data and clinical experience in this timeframe accrue. Necessary active and future research include the identification and characterization of key clinical, serological, imaging and epidemiologic features of COVID-19 in the acute, subacute and chronic phases of disease, which will help us to better understand the natural history and pathophysiology of this new disease entity (Table 2). Active and future clinical studies, including prospective cohorts and clinical trials, along with frequent review of emerging evidence by working groups and task forces, are paramount to developing a robust knowledge database and informing clinical practice in this area. Currently, healthcare professionals caring for survivors of acute COVID-19 have the key role of recognizing, carefully documenting, investigating and managing ongoing or new symptoms, as well as following up organ-specific complications that developed during acute illness. It is also imperative that clinicians provide information in accessible formats, including clinical studies available for participation and additional resources such as patient advocacy and support groups.

            Moreover, it is clear that care for patients with COVID-19 does not conclude at the time of hospital discharge, and interdisciplinary cooperation is needed for comprehensive care of these patients in the outpatient setting. As such, it is crucial for healthcare systems and hospitals to recognize the need to establish dedicated COVID-19 clinics74, where specialists from multiple disciplines are able to provide integrated care. Prioritization of follow-up care may be considered for those at high risk for post-acute COVID-19, including those who had severe illness during acute COVID-19 and/or required care in an ICU, those most susceptible to complications (for example, the elderly, those with multiple organ comorbidities, those post-transplant and those with an active cancer history) and those with the highest burden of persistent symptoms.

            Given the global scale of this pandemic, it is apparent that the healthcare needs for patients with sequelae of COVID-19 will continue to increase for the foreseeable future. Rising to this challenge will require harnessing of existing outpatient infrastructure, the development of scalable healthcare models and integration across disciplines for improved mental and physical health of survivors of COVID-19 in the long term.

  4. Liam

    quote in one of the papers from a pharmacist saying he could vaccinate “up to 100 people a week”

    surely there’s a better/quicker way of doing this? Most of the pharmacies in my town have opted out as they don’t have the space for the waiting area. meanwhile every school hall in the town is empty and locked up for the summer.

    1. george

      Liam, mass vaccination is happening daily in vaccination centres all over the country. Do you not pay attention to the news at all?

      The use of pharmacies is a way of adding some additional capacity. The pharmacists can’t leave their shops for a month to work in a school hall.

Comments are closed.

Sponsored Link